CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 06/30/2022 | 03/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | 5.56% | 109.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.56% | 109.87% | |||
| Cost of Revenue | -16.59% | 65.94% | |||
| Gross Profit | 26.36% | 181.18% | |||
| SG&A Expenses | -25.29% | -78.11% | |||
| Depreciation & Amortization | 2.26% | -- | |||
| Other Operating Expenses | -17.86% | -15.15% | |||
| Total Operating Expenses | -23.49% | -75.50% | |||
| Operating Income | 28.29% | 78.62% | |||
| Income Before Tax | 28.29% | 78.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.29% | 78.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.29% | 78.62% | |||
| EBIT | 28.29% | 78.62% | |||
| EBITDA | 30.26% | -- | |||
| EPS Basic | 28.57% | 81.74% | |||
| Normalized Basic EPS | 30.77% | 81.94% | |||
| EPS Diluted | 28.57% | 81.74% | |||
| Normalized Diluted EPS | 30.77% | 81.94% | |||
| Average Basic Shares Outstanding | 0.00% | 17.95% | |||
| Average Diluted Shares Outstanding | 0.00% | 17.95% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
